Quantcast

Latest Merrimack Pharmaceuticals Inc. Stories

2011-04-02 00:00:28

MM-111 in pre-clinical combinations with lapatinib and endocrine therapies MM-302 in pre-clinical studies explaining its mechanism of action Cambridge, Mass. (Vocus/PRWEB) April 01, 2011 Merrimack Pharmaceuticals, Inc.

2011-03-31 00:00:29

Robert Mulroy, President and Chief Executive Officer, will provide a company overview at Needham & Company’s 10th Annual Healthcare Conference. Cambridge, MA (Vocus/PRWEB) March 30, 2011 Merrimack Pharmaceuticals today announced that it will present at Needham & Company’s 10th Annual Healthcare Conference in New York City, New York.

2011-03-04 00:00:30

Robert Mulroy, President and Chief Executive Officer, will provide a company overview at Cowen and Company 31st Annual Health Care Conference Cambridge, Mass.

2010-12-22 00:01:33

Robert Mulroy, President and Chief Executive Officer of Merrimack Pharmaceuticals, will provide a company overview at the 29th Annual JP Morgan Healthcare Conference in San Fransisco, California CAMBRIDGE, Mass.

2010-12-10 00:00:58

MM-111 first-in-human phase 1/ 2 and pharmacologic study in patients with advanced refractory HER2-Positive (HER2+) cancers.

2010-11-23 00:01:10

Robert Mulroy, President and Chief Executive Officer, will provide a company overview at the Piper Jaffray 22nd Annual Health Care Conference. (Vocus/PRWEB) November 22, 2010 Merrimack Pharmaceuticals today announced that it will present at the Piper Jaffray 22nd Annual Health Care Conference in New York City, New York.

2010-09-13 10:22:00

CAMBRIDGE, Mass., Sept. 13 /PRNewswire/ -- Merrimack Pharmaceuticals today announced that it will present at the Stifel Nicolaus 2010 Healthcare Conference in Boston.


Word of the Day
adustion
  • The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
  • In medicine, cauterization.
The word 'adustion' comes from the Latin 'adustio', 'burning'.
Related